VV

vVARDIS Holding AG

VVVV · NYSE · Healthcare / Medical Instruments & Supplies

14.55USD

Price History

Full chart

Market Stats

Open14.89
Day Range14.54 – 14.97
52-Week Range14.00 – 16.95
Volume341.50K
Market Cap770.91M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.29
Dividend Yield0.00%
50-Day Avg15.55
200-Day Avg15.55

About

vVARDIS Holding AG, a dental medtech company, develops and provides non-invasive cavity treatment products in Switzerland and the United States. The company offers the Curodont platform, including Curodont Repair, a biomimetic system to arrest and reverse early caries through enamel regeneration; Curodont Protect, a remineralising tooth gel containing the biomimetic Oligo-Peptide 103 technology; and Enamel Serum, enriched with peptides and hydroxyapatite, which delivers calcium and phosphate ions to care for the enamel. The company was incorporated in 2020 and is based in Zug, Switzerland. vVARDIS Holding AG operates as a subsidiary of VVARDIS Investment Holding AG.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Thomas Rondot
  • Employees153
  • HeadquartersGubelstrasse 24, Zug, Switzerland, 6300, USA
  • Websitehttps://www.vvardis.com

Leadership

  • Mr. Thomas RondotCFO & Chief People Officer · b. 1973

Financials

Income Statement

Currency: USD2024-12-312025-12-31
Total Revenue12.16M30.21M
Growth (%)-+148.49%
Cost of Revenue8.27M7.79M
Gross Profit3.89M22.42M
Gross Margin31.98%74.21%
Operating Expense34.85M64.50M
Operating Income-30.97M-42.08M
Operating Margin-254.72%-139.31%
EBITDA-27.30M-41.10M
EBITDA Margin-224.55%-136.07%
Net Income-34.74M-56.49M
Net Income Margin-285.74%-187.01%
R&D2.64M4.58M
R&D as % of Total Revenue21.72%15.14%
Interest Expense3.94M11.75M
Interest Expense % of Total Revenue32.43%38.91%

Balance Sheet

Currency: USD2024-12-312025-12-31
Total Assets55.91M83.23M
Total Liabilities131.88M188.02M
Total Equity-74.94M-103.66M
Cash2.34M17.47M
Net Debt70.60M87.13M

Cash Flow

Currency: USD2024-12-312025-12-31
Operating Cash Flow-23.80M-16.33M
Financing Cash Flow27.13M31.98M
Capital Expenditure325.00K2.81M
Free Cash Flow-24.12M-19.14M
FCF to OCF101.37%117.17%

Key Statistics & Ratios

Market Cap770.91M
Enterprise Value2.79B
Trailing P/E0.00
Forward P/E0.00
Price / Sales15.52
Price / Book0.00
EPS-0.29
Book Value-3.43
Revenue (TTM)49.68M
Gross Profit (TTM)42.42M
EBITDA-29.79M
Profit Margin-105.16%
Operating Margin-68.89%
Return on Equity0.00%
Return on Assets0.00%
Shares Outstanding38.59M
Shares Float2.96M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%